Fecal microbiota transplantation: A ‘How-To’ guide for nurses

Published:October 13, 2014DOI:


      Fecal microbiota transplantation is emerging as one of the most exciting treatments of this century. Rarely has one treatment provided the opportunity to treat a myriad of diseases, not only within the gastrointestinal tract but also in extra-intestinal organs; such is the power of the gastrointestinal microbiota to modulate the immune system and eradicate infections, even where antibiotics have previously failed. The demand for this therapy, both among patients and physicians, is increasing, and a search of the literature reveals numerous reviews, case reports and discussion on the topic. However, to date, much of the literature addresses the procedure from a physician's point of view, and can therefore be lacking in practical detail. As nurses are often the ‘unsung heroes’ of the procedure, it is timely to address the subject from a nursing perspective.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Collegian
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Adlerberth I.
        • Huang H.
        • Lindberg E.
        • Aberg N.
        • Hesselmar B.
        • Saalman R.
        • et al.
        Toxin-producing Clostridium difficile strains as long-term gut colonizers of healthy infants.
        Journal of Clinical Microbiology. 2013;
        • Bakken J.S.
        • Borody T.
        • Brandt L.J.
        • Brill J.V.
        • Franzos M.A.
        • Kelly C.
        • et al.
        Treating Clostridium difficile infection with fecal microbiota transplantation.
        Clinical Gastroenterology and Hepatology. 2011; 9: 1044-1049
        • Borody T.J.
        • Campbell J.
        Fecal microbiota transplantation: Current status and future directions.
        Expert Review of Gastroenterology & Hepatology. 2011; 5: 653-655
        • Borody T.J.
        • George L.
        • Andrews P.
        • Brandl S.
        • Noonan S.
        • Cole P.
        • et al.
        Bowel flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?.
        Medical Journal of Australia. 1989; 150: 604
        • Borody T.J.
        • Khoruts A.
        • Campbell J.
        Fecal microbiota transplantation and emerging applications.
        Nature Reviews. Gastroenterology & Hepatology. 2012; 9: 88-96
        • Borody T.J.
        • Paramsothy S.
        • Agrawal G.
        Fecal microbiota transplantation: Indications, methods, evidence, and future directions.
        Current Gastroenterology Reports. 2013; 15: 337
        • Borody T.J.
        • Peattie D.
        • Kapur A.
        Could fecal microbiota transplantation cure all Clostridium difficile infections?.
        Future Microbiology. 2014; 9: 1-3
        • Borody T.J.
        • Warren E.F.
        • Leis S.M.
        • Surace R.
        • Ashman O.
        • Siarakas S.
        Bacteriotherapy using fecal flora: Toying with human motions.
        Journal of Clinical Gastroenterology. 2004; 38: 475-483
        • Brandt L.
        • Aroniadis O.
        An overview of fecal microbiota transplantation: Techniques, indications and outcomes.
        Gastrointestinal Endoscopy. 2013; 78: 240-249
        • Brandt L.
        • Aroniadis O.
        • Greenberg A.
        • Borody T.
        • Finlayson S.
        • Furnari V.
        • et al.
        Safety of fecal microbiota transplantation (FMT) in immunocompromised (Ic) patients with inflammatory bowel disease (IBD).
        American Journal of Gastroenterology. 2013; 108: S556
        • Brandt L.J.
        • Aroniadis O.
        • Mellow M.
        • Kanatzar A.
        • Kelly C.
        • Park T.
        • et al.
        Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.
        American Journal of Gastroenterology. 2012; 107: 1079-1089
        • Brandt L.J.
        • Borody T.J.
        • Campbell J.
        Endoscopic fecal microbiota transplantation: “First-line” treatment for severe Clostridium difficile infection.
        Journal of Clinical Gastroenterology. 2011; 45: 655-657
        • De Leon L.M.
        • Watson J.B.
        • Kelly C.R.
        Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection.
        Clinical Gastroenterology & Hepatology. 2013; 11: 1036-1038
        • Gough E.
        • Shaikh H.
        • Manges A.R.
        Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection.
        Clinical Infectious Disease. 2011; 53: 994-1002
        • Hamilton M.J.
        • Weingarden A.R.
        • Sadowsky M.J.
        • Khoruts A.
        Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection.
        American Journal of Gastroenterology. 2012; 107: 761-767
        • Hopkins M.J.
        • Sharp R.
        • Macfarlane G.T.
        Variations in human intestinal microbiota with age.
        Digestive & Liver Disease. 2002; 34: S12-S18
        • Kassam Z.
        • Lee C.
        • Yuan Y.
        • Hunt R.H.
        Fecal microbiota transplantation for Clostridium difficile infection: Systematic review and meta-analysis.
        American Journal of Gastroenterology. 2013; 108: 500-508
        • Marinska A.
        Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection.
        American Nurse Today. 2013; 8: 1-2
        • Quera R.
        • Espinoza R.
        • Estay C.
        • Rivera D.
        Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection.
        Journal of Crohn's & Colitis. 2013; 13: S1873-S9946
        • Rohlke F.
        • Stollman N.
        Fecal microbiota transplantation in relapsing Clostridium difficile infection.
        Therapeutic Advances in Gastroenterology. 2012; 5: 403-420
        • Schwartz M.
        • Gluck M.
        • Koon S.
        Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts.
        American Journal of Gastroenterology. 2013; 108: 1367
        • Smits L.P.
        • Bouter K.E.
        • De Vos W.M.
        • Borody T.J.
        • Nieuwdorp M.
        Therapeutic potential of fecal microbiota transplantation.
        Gastroenterology. 2013; 145: 946-953
        • van Nood E.
        • Vrieze A.
        • Nieuwdorp M.
        • Fuentes S.
        • Zoetendal E.G.
        • De Vos
        • et al.
        Duodenal infusion of donor feces for recurrent Clostridium difficile.
        New England Journal of Medicine. 2013; 368: 407-415